Technical Articles
UA040394
Where IGFBP-5 Gets Asked: Four Scenarios and Their Evidence Requirements
Bone metabolism, fibrosis, tumor stroma and IGF-carrier formulation studies each interrogate IGFBP-5 differently. This article maps the four directions.
View details
- Signaling Pathway
- IGFBP-5
- bone metabolism
- fibrosis
- tumor stroma
- IGF carrier
- UA040394
Getting IGFBP-5 Experiments to Count: Three Design Groups plus Five Moves
A design-first guide to IGFBP-5: ligand-trap vs release conditions, matrix-present vs matrix-free setups and five handling moves that protect the readout.
View details
- Signaling Pathway
- IGFBP-5 assay
- reconstitution
- dose curve
- control design
- IGF release
- UA040394
Why IGFBP-5 Sequesters Ligand While Binding Matrix: One Chain with Two Jobs
IGFBP-5 carries an IGF-binding pocket and a heparin/matrix-binding face on one chain. This article maps the dual-track behavior and what each track changes.
View details
- Signaling Pathway
- IGFBP-5
- IGF binding protein
- matrix binding
- heparin
- IGF bioavailability
- UA040394
- 1








